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Abstract: Uncultured bacteria from sponges have been 
demonstrated to be responsible for the generation of many 
potent, bioactive natural products including halogenated 
metabolites.1 The identification of gene clusters from the 
metagenomes of such bacterial communities enables the 
discovery of enzymes that mediate new and useful 
chemistries and allows insight to be gained into the 
biogenesis of potentially pharmacologically important 
natural products. Here we report a new pathway to the 
keramamides (krm); the first functional evidence for the 
existence of a distinct producer in the Theonella(swinhoei WA 
chemotype is revealed, and a key enzyme on the pathway, a 
unique flavin dependent halogenase with a broad substrate 
specificity, and with potential as a useful new biocatalytic 
tool is described. 
Introduction: Sponges have been shown to be a rich source of 
bioactive molecules, including halometabolites, and an 
exciting treasure trove in which to search for new enzymes. 
Halogenation represents an important strategy for tuning and 
improving bioavailability and bioactivity of molecules, and is 
attracting increasing interest from academia and industry 
alike. Over 4000 halogenated natural products have been 
identified to date, many of which exhibit potent 
bioactivities.1 Keramamides and related compounds (Figure 
1) are a unique series of halogenated marine non-ribosomal 
peptide natural products that have been shown to be 
cytotoxic against murine and human cancer cell lines.2  
Due to conferring favorable properties, halogenation is used 
prolifically by both agrochemical and pharmaceutical 
industries, with around 20% of small molecule drugs and 
30% of agrochemical compounds being halogenated.3 In 
2013, the top-revenue drug in the USA was the 2,3-
dichlorophenyl-containing antipsychotic aripiprazole 
(Abilify).4 Furthermore, the introduction of halogens into 
molecules can provide sites for selective functionalization 
through cross-coupling chemistries.5 Synthetic conditions for 
halogenation are often harsh and non-regioselective, utilize 
noxious reagents, or generate undesirable by-products6 and 
there is an increasing demand for the discovery and 
development of halogenases as new tools for (bio-)catalysis. 
In contrast to synthetic approaches, halogenases are able to 
regioselectively introduce halogens under mild and green 
conditions without generating harmful waste. As a result, 
halogenases are attracting much attention.7–15  
 
Figure 1 Symbiont-derived natural products containing the 
halo-hydroxytryptophan motif (highlighted in blue) that have 
been identified from extracts of T. swinhoei chemotypes. 
Two distinct halohydroxytryptophan motifs are observed: 2-
bromo-5-hydroxytryptophan and 6-chloro-5-
hydroxytryptophan. Keramamide H (1), keramamide A (2), 
konbamide (3), orbiculamide A (4).!
Keramamides contain rare halohydroxytryptophans motifs. 
Notably, the marine sponge Theonella swinhoei has been 
identified as the source of several natural products that 
contain this moiety, including konbamide,14 and 
orbiculamide15 (e.g., 1–4, Figure 1) as well as the 
keramamides.2,16 Intriguingly, distinct variants of these 
compounds occur in different chemotypes of the sponge. 
Orbiculamide A (4) (containing a 2-bromo-5-
hydroxytryptophan moiety) is found in the chemotype T. 
swinhoei Y, which is named to reflect the characteristic 
 yellow color of the sponge interior (Figure 1).17 T. swinhoei 
chemotype WA (white interior from Hachijo Island, Japan) 
was not previously reported to contain such peptidic natural 
products. 
 
RESULTS AND DISCUSSION 
 
A new krm gene cluster from T. swinhoei WA 
By identifying the biosynthetic genes, it was recently 
demonstrated that keramamide-type peptides and many other 
natural products isolated from T. swinhoei Y are produced by 
an as-yet-uncultured bacterial symbiont of the sponge, 
Candidatus ‘Entotheonella factor’ TSY1.17 The sponge T. 
swinhoei WA examined in the current study was also 
previously shown to contain filamentous ‘Entotheonella’ 
symbionts.17 In this sponge, ‘Entotheonella serta’ TSWA1 is 
the source of the homodimeric polyketide actin inhibitor 
misakinolide A.18 Here, using an enriched ‘Entotheonella’ 
cell fraction prepared from T. swinhoei WA, PCR analysis 
with primers specific for adenylation (A) domain-encoding 
regions of nonribosomal peptide synthetase (NRPS) genes 
revealed the presence of homologous genes. These were 
closely related to those of the keramamide (ker) biosynthetic 
genes previously identified in ‘E. factor’ associated with T. 
swinhoei Y. To isolate the corresponding genomic locus, a 
fosmid library was constructed from the enriched 
‘Entotheonella’ cell fraction of the WA chemotype and 
screened, resulting in the isolation of fosmid pADU2a. 
Sequencing of his fosmid confirmed the presence of NRPS 
and polyketide synthase (PKS) genes sharing high similarity 
and architectural features with the ker cluster (Figures 2 and 
S1, Table S3). Notable differences of the krm biosynthetic 
gene cluster to the ker system, included krmR, and krmI.  
Keramamides identified from T. swinhoei WA exhibit an O-
methylserine extension as present in keramamide H (1, 
Figure 1), and krmR is predicted to encode an NRPS module 
activating and incorporating O-methylserine. The C-terminal 
region of KrmI resembles flavin-dependent tryptophan 
halogenases (FDTHs). FDHs are typically found encoded 
within a natural product biosynthetic pathway gene cluster, 
and many are known to halogenate indole, phenol, and 
pyrrole motifs. Though halotryptophans occur fairly 
frequently in natural products, such halohydroxytryptophans 
are far less common. 
 
 
Challenged by the low concentration of keramamides in the 
sponge tissue, which is itself of limited availability, and the 
current unculturable nature of ‘Entotheonella’ from either T. 
swinhoei WA or Y1, we set out to use comparative MS 
analysis to analyze the chemistry produced by the sponge 
microbiomes and to glean evidence for the activity of the 
newly identified krm gene cluster. Strikingly, our analysis 
revealed the presence of numerous keramamide congeners 
from each system. Figures S2 and S3 show a molecular 
network analysis of extracts from both chemotypes. Whilst 
the MS2 characteristics of some T. swinhoei WA compounds 
matched those of known keramamides, others are unique and 
observed for the first time.  
 
 
Figure 2. (A) The previously identified keramamide (ker) 
biosynthetic gene cluster from T. swinhoei Y. (B) Newly 
identified krm keramamide-type gene cluster from T. 
swinhoei WA containing the unusual 5-hydroxy-6-
halotryptophan gene, (C) Biosynthetic model for the ker 
pathway. (D) Predicted function of the krm pathway, in 
which the halogenase KrmI functionalizes the 6 position of 
the indole. (See table S1 for further information on the genes 
identified in the krm pathway.14 ) 
The detection of more than a dozen different keramamide 
congeners in both chemotypes might indicate an inherent 
flexibility of the krm-encoded adenylation domains, often 
observed for NRPS pathways, which seem to accept series of 
similar amino acids. From the comparative MS network 
analysis, the position of halogenation cannot be determined 
Challenged by the limited amounts of material available, as 
NMR analysis of the WA keramamides would not be a 
possible method for us to determine the regiochemistry of the 
halogenation, we next set out to directly investigate the 
unusual associated halogenase KrmI.  
 
Bioinformatic analysis of krmI 
Bioinformatic analysis of the gene krmI at the translated 
amino acid level using BLAST19 and HHPred20 (SI Tables 
S2 and S3) indicated that the C-terminus of the protein KrmI 
is homologous to known halogenases including RebH (30% 
identity, 48% similarity over homologous region), PrnA 
(30% / 47%), and CmdE (21% / 35%), and contains the well-
characterized sequence motifs for FDTHs - GxGxxG and 
 WxWxIP - as well as mechanistically relevant residues 
(Lys443 and Glu696 align to Lys79 and Glu346 from PrnA) 
(SI figure S3).21–23 Unusually, KrmI appears to include a 
second, N-terminal domain-like region with distant 
homology to members of the ThiF enzyme family (Pfam 
family ThiF PF00899). Typically, these enzymes utilize ATP 
to activate carboxylic acids by adenylation.24,25 Whilst 
sequence identity to characterized protein sequences is low, 
the alignment revealed that in KrmI, this domain is truncated 
and the majority of residues involved in substrate and co-
factor binding are likely to be absent, although we must be 
cautious making definite claims based on alignments of such 
distantly related proteins. Only one other sequence 
displaying this unusual combination of truncated ThiF-like 
and FDTH domains has been deposited in the NCBI non-
redundant protein sequence database; this hypothetical 
protein is uncharacterized and no information on the context 
of this gene is available.26 The ThiF family is similar to the 
E1-like proteins that have been implicated in the specific 
binding of peptide substrates in ribosomal peptide natural 
product biosynthesis,27,28 and it is possible that the C-
terminal domain serves a similar function here.  
 
 
Figure 3. A graphical representation of KrmI with its two 
enzymatic domains in grey (top, numbered by translated 
amino acid position),  and  homologous  regions  of  Pfam  
protein  families  PF00899  (ThiF, green) and PF04820 
(PrnA Trp Halogenase, red) that were identified using 
HHpred.20 Similarity between KrmI domains and the PFAM 
representatives to which they are compared are indicated by a 
grey-scale similarity representation with black showing high 
levels of similarity and light grey showing low levels of 
similarity. 
 
Production of KrmI 
To determine whether krmI encodes an active halogenase, 
and whether both domains are necessary for activity, two 
expression constructs were prepared. The first encoded the 
full-length gene, whilst the second encoded only the C-
terminal domain (truncated to the first in-frame ATG codon 
preceding the FDTH domain). Both constructs produced little 
soluble protein when expressed in Escherichia coli unless the 
chaperone proteins GroEL/S, DnaK/J and GrpE were co-
expressed. Though the production of many other halogenases 
in heterologous expression hosts do not require the use of 
chaperones;29–32 chaperones GroEL/S has previously been 
reported to improve the solubility and yield of RebH when 
produced in E. coli.11 
 
Coexpression of genes encoding GroEL/S, DnaK/J and GrpE 
along with KrmI resulted in adequate levels of production of 
soluble KrmI (Figures S6 and S7). Attempts to produce 
either protein as an N-terminal maltose binding protein 
(MBP) fusion resulted in complete loss of solubility, whilst 
the presence of a polyhistidine tag at either terminus had only 
a slightly detrimental effect on solubility. A significant 
proportion of the soluble protein did not bind to nickel 
nitrilotriacetic acid (NiNTA) resin during immobilized metal 
affinity purification (IMAC), indicating that the polyhistidine 
tag may have low accessibility. IMAC purification of this 
enzyme is low-yielding (approximately 1 mg protein per L E. 
coli culture). We demonstrated, however, that the crude cell 
lysate (CCL) containing KrmI could be readily utilized as a 
biocatalyst, without any detrimental effect on the reaction, 
and therefore KrmI was used as a component of the CCL 
throughout the majority of the work reported here.  
 
Halogenation assays & product characterization 
The gene was shown to encode a functional halogenase as in 
vitro assays demonstrated that the full-length protein was 
able to convert 5-hydroxytryptophan (5HTP, 5) to a single 
new product when the enzyme was utilized as a component 
of a CCL (Scheme 1). LC-HRMS was used to identify the 
accurate mass of this product, suggesting a chemical formula 
of C11H11N2O2Cl and indicating that 5HTP (5) had been 
regioselectively chlorinated by KrmI ([M+H]+ = 
C11H12N2O3Cl calculated: 255.0536; measured: 255.0532 Δ: 
+0.2 ppm). Use of the truncated protein resulted in only trace 
conversion to 6Cl5HTP (Figure 4C), and the purified 
enzymes also showed greatly reduced activity (Figure 4D 
and 4G) compared to the full-length protein. Hence it was 
decided to utilize KrmI as a component of the CCL for the 
rest of this study.   
 
 
Scheme 1. KrmI converts 5HTP (5) to 6Cl5HTP (6). A 
simplified catalytic cycle for the required co-factor FAD/H2, 
which is generated in situ by the flavin reductase PrnF, is 
shown. 
  
 
Figure 4. Halogenation of 5HTP (5) achieved utilizing 
various KrmI preparations. The conversion of 5HTP to 
6Cl5HTP, as monitored by UPLC, at an absorbance at 300 
nm is depicted. Assay conditions are described in the SI. (A) 
5HTP (5) standard, (B) Full-length KrmI as a component of a 
CCL (0.6 mU/mL). (C) truncated C-terminal domain of 
KrmI as a component of the CCL (trace activity). (D) 
Purified full-length KrmI (20 µM, 0.1 mU/mL). (E) Purified 
full-length KrmI + E. coli CCL (20 µM, 0.3 mU/mL), (F) 
Purified full-length KrmI + catalase + SOD (20 µM, 0.6 
mU/mL). (G) Purified C-terminal domain (20 µM, <0.1 
mU/mL). (H) Purified C-terminal domain + catalase + SOD 
(20 µM, <0.1 mU/mL). 1 mU is the amount of enzyme that 
converts 1 nmol of 5HTP (5) to 6Cl5HTP (6) per minute 
under assay conditions. 
 
Exclusively in the case of the full-length purified protein, it 
was possible to restore activity by supplementing with either 
a CCL prepared from E. coli expressing an empty vector 
(Figure 4E) or with catalase and superoxide dismutase 
(SOD) (Figure 4F), implying that the protein may be harmed 
by reactive oxygen species (ROS) generated in situ. Other 
FDTHs reported in the literature have been active upon 
purification without the need for the inclusion of any further 
additives to counter the effect of ROS.29,30,33  
 
In order to fully characterize the product and identify the 
regiochemistry of halogenation, the reaction was scaled up to 
10 mg, which allowed the product to be purified and 
analyzed by 1H NMR. As the aromatic region of the 1H and 
COSY NMR spectra were devoid of coupling, it could be 
concluded that halogenation has taken place at position 6 and 
the three observed singlet aromatic resonances correspond to 
the protons at positions 2, 4, and 7 of the indole ring.  6-
chloro-5-hydroxytryptophan (6Cl5HTP) has previously been 
described in the literature,34 and the 1H NMR 
characterization agrees with that reported here. The single 
product generated by the KrmI-catalyzed regioselective 
chlorination of 5HTP (5) was therefore confirmed as 
6Cl5HTP (6) (Scheme 1), a likely biosynthetic precursor to 
keramamide A (2) and other congeners. 
 
Halide and substrate scope 
Having determined that KrmI is able to chlorinate 5HTP, we 
next sought to explore whether it could also catalyze 
bromination or iodination of the same substrate. As the 
enzyme was used in the form of a CCL, it was not practical 
to completely eliminate endogenous sodium chloride from 
the preparation; however, we found that the enzyme was able 
to tolerate the addition of salt to the CCL. Therefore, we 
performed assays in the presence of additional sodium 
chloride, sodium bromide, and potassium iodide. As is 
typical for FDTH,30,33,35 KrmI is able to utilize chloride and 
bromide but not iodide, with reduced activity when 
incorporating bromide (Figures 5 and 6). 
 
 
 
Figure 5. UPLC chromatograms (UV absorbance at 300 nm) 
monitoring the products of 5HTP (5) halogenation by KrmI 
in the presence of NaCl (A), NaBr (B), and KI (C). A small 
amount of NaCl is present in all assays, leading to the 
production of 6Cl5HTP. In the presence of bromide, an 
additional new product is formed, which was determined to 
be 6Br5HTP. 
Figure 6. Product distribution of 5HTP (5) halogenation by 
KrmI in the presence of varying additional concentrations of 
Cl- and Br-. UPLC peak areas (300 nm) are plotted as 
normalized values. 6Cl5HTP: filled circles, 6Br5HTP: open 
circles, total 6-halo-5-HTP: crosses & dashed line. Error bars 
indicate the standard deviation of triplicate measurements 
and are in many cases obscured by the data markers. 
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The brominated product was isolated from a scaled-up 
reaction and characterized by 1H NMR, which indicated that 
regioselectivity had been retained and the product was 6-
bromo-5-hydroxytryptophan (6Br5HTP). By combining 
sodium bromide and sodium chloride in varying ratios in the 
assay, we were able to determine that bromination occurred 
in preference to chlorination despite chloride being present in 
higher concentrations and a decrease in overall conversion of 
the starting material (Figure 6). 
 
FDTH are known to halogenate a range of substrates,11,12,32 
typically tryptophan derivatives and other aromatic moieties. 
To initiate a study of the substrate scope for this unusual 
halogenase we first explored whether the enzyme might 
halogenate tryptophan and serotonin, as they are closely 
related to 5HTP. Indeed, KrmI was able to halogenate 
serotonin and 5HTP with approximately equal efficiency in 
terms of time and conversion levels, whilst tryptophan was 
less well tolerated as a substrate (Figure 7). To our 
knowledge, the only other FDTH with a preference for a 
substituted tryptophan is KtzR, which installs chlorine at the 
6-position of 7-chlorotryptophan in the biosynthesis of 
kutzneride.36 
 
Encouraged by these initial results, we extended our study of 
the substrate scope of KrmI. Again we utilized crude lysate 
containing the full-length protein in incubations with a 
variety of potential substrates (Figure 8). We observed good 
levels of conversion for the substrates L-5HTP (5), serotonin 
(10), and 5- methoxyindole (18); and lower levels of 
conversion for L-tryptophan (8), D-tryptophan (12) and 5-
aminoindole (19). We determined that L-7-fluorotryptophan 
(13), L-7-hydroxytryptophan (14), 4-hydroxyindole (15), 5-
hydroxyindole (16), 5-hydroxyindole-3-acetic acid (17), 5-
formylindole (20), and 7-azaindole (21) could also be 
processed by KrmI, but at trace level as indicated by LC-MS 
measurements. All substrates were converted to a single new 
mono-chlorinated product, with the exception of 5-
aminoindole (19), which was converted into two halogenated 
products (LC-HRMS analysis of all halogenated substrates is 
included in the SI). This indicates that KrmI is able to 
regioselectively halogenate a range of substrates, although 
due to low levels of product, the position of halogenation has 
not been confirmed in all cases. The acceptance of 5-
hydroxyindole (16), 5-methoxyindole (18) and 5-
aminoindole (19) but not of 5-fluoroindole (30) or 5-
fluorotryptophan (generated in situ from 30) may suggest 
that specificity within the active site could arise from the 
requirement for a hydrogen bond acceptor within the ring, 
rather than steric requirements, as 5-fluorotryptophan is 
isosteric to the preferred substrate 5HTP. There is clearly 
considerable substrate flexibility as 5-formylindole (20) and 
4-hydroxyindole (15) were also accepted. The 
accommodation of both L- and D-tryptophan (8 and 12) 
demonstrates that this hydrogen bonding interaction is not an 
absolute requirement, and that interactions with the amino 
acid moiety are flexible.  
 
Figure 7 UPLC chromatograms of the halogenation of 5HTP 
((A), 300 nm), tryptophan ((B), 280 nm), and serotonin ((C), 
300 nm). The identities of the labelled peaks have been 
confirmed by LC-HRMS and NMR. 
Conclusions 
Through metabolite extraction and MS network analysis we 
show that T. swinhoei WA (white chemotype), like its yellow 
counterpart, T. swinhoei Y produces keramamides. Whilst 
the keramamide series of compounds produced by T. 
swinhoei WA and Y partially overlap, they also show distinct 
chemotype-specific characteristics. The discovery of the new 
biosynthetic gene cluster (e.g. krmI) from the metagenome of 
the sponge T. swinhoei WA explains the difference in the 
suites of compounds produced in each system. The krm 
genes, though showing homology to the previously identified 
ker gene cluster, exhibit distinct differences; a key difference 
is the presence of krmI. Biooinformatic analysis of krmI 
indicated it to be a flavin-dependent halogenase. Functional 
analysis of the encoded protein product, revealed a 
catalytically active halogenase with an in vitro substrate 
preference for 5-hydroxytryptophan over tryptophan, 
generating 6-halo-5-hydroxytryptophan as a single 
regioisomer, indicating that this halogenase operates to 
generate the 6-halo containing keramamides. It is likely that 
a second, as yet unidentified halogenase acts to generate the  
  
Figure 8. Substrate specificity of KrmI. Substrates shown 
above the bold line were halogenated, whilst those shown 
below the bold line were not. Substrates 13 and 14 were 
generated in situ from the corresponding indole by the native 
E. coli tryptophan synthase. The substrates that were 
halogenated include: L-5HTP (5), L-tryptophan (8), 
serotonin (10), D-tryptophan (12), 7-fluorotryptophan (13), 
7-hydroxytryptophan (14), 4-hydroxyindole (15), 5-
hydroxyindole (16), 5-hydroxyindole-3-acetic acid (17), 5-
methoxyindole (18), 5-aminoindole (19), 5-formylindole 
(20), and 7-azaindole (21). The enzyme did not process: L-
phenylalanine (22), L-tyrosine (23), DL-metatyrosine (24), 
L-histidine (25), indole (26), 6-hydroxyindole (27), 7-
hydroxyindole (28), 4-fluoroindole (29), 5-fluoroindole (30), 
6-fluoroindole (31), 7-fluoroindole (32), 4-chloroindole (33), 
5-chloroindole (34), 6-chloroindole (35), 7-chloroindole (36), 
2-formylindole (37), 7-formylindole (38), 5-nitroindole (39) 
and 7-nitroindole (40).  
 
2-halo containing keramamides observed within the T. 
swinhoei Y system. 
 
KrmI is the first halogenase identified to use L-5-
hydroxytryptophan as its preferred substrate. Furthermore 
another unique characteristic is the unusual N-terminal 
region of the protein.  Though no function has been assigned 
to the N-terminal domain, in our hands, the mono-domain 
truncation demonstrated considerably lower activity 
compared to its full-length counterpart. Our initial 
investigations of KrmI as a potential tool for biocatalysis 
demonstrate that it has promisingly broad substrate 
specificity. KrmI can accommodate a range of indole-derived 
substrates. Future work will include crystallographic analysis 
which may provide insight into substrate flexibility and 
informed engineering of the enzyme to further develop it for 
biotechnological applications. KrmI is an efficient catalyst 
for the production of halogenated 5HTP and serotonin, and 
due to its inherent substrate flexibility presents a promising 
starting point for the generation of a range of chlorinated and 
brominated products following protein engineering. 
 
It is notable that halogenation was almost exclusively 
observed at the 6-position of the indole ring in these studies, 
whilst in the keramamide congeners halogenation is observed 
at both the 2- and the 6-positions. It seems likely, therefore, 
that there is either another halogenase in the keramamide 
gene clusters that is responsible for halogenation at the 2-
position of the indole ring, or KrmI possesses an activity in 
vivo which is not observed in vitro. It is tempting to postulate 
that the C-terminal domain may be responsible to binding a 
peptide substrate, and that the true activity of KrmI would 
not be observed when the enzyme acts on a free amino acid 
substrate rather than a peptide substrate. The instability of 2-
halotryptophans, in which loss of halogen is promoted by the 
free carboxylate or even amine positioning over the indole 
ring37,38 makes it likely that halogenation at the 2-position 
does not occur on free tryptophan substrates. Such 
halogenation is more likely to occur once the tryptophan 
substrate is integrated into a peptide, where both N- and C-
termini are functionalized as amides. 
 
This study adds further functional evidence to the role of 
symbiotic bacteria in the production of sponge-derived 
natural products. Whilst keramamides have previously been 
assigned to ‘E. factor’ in the chemotype T. swinhoei Y,17 the 
source of the halogenated congeners in T. swinhoei WA 
remains unknown. In another study of the WA chemotype, 
the polyketide misakinolide A was assigned to the symbiont 
‘E. serta’ TSWA1 by single-cell genome sequencing;18 
however, analysis of that sequence data did not reveal the 
presence of keramamide genes, suggesting that these 
compounds are likely to be produced by either a different 
‘Entotheonella’ phylotype or another symbiotic bacterium 
found in the sponge. 
 
METHODS 
 Isolation of krm genes from the metagenome of T. swinhoei 
WA 
DNA was isolated from a previously described17 
‘Entotheonella’-enriched bacterial fraction of T. swinhoei 
WA following a procedure adapted from Syn and Swarup. 
PCR using degenerate primers was used to amplify gene 
fragments corresponding to NRPS A domains, which were 
purified, ligated into pBlueScript II (SK-) (Stratagene) and 
sequenced. A second round of PCR using specific primers 
enabled identification of the fosmid pADU2a containing the 
krm cluster. 
 
Metabolic analysis 
Metabolites were extracted from T. swinhoei Y and WA 
tissue samples and analyzed by LC-MS-MS using a Thermo 
QExactive mass spectrometer operating in positive ionization 
mode and using data-dependent acquisition of fragmentation 
spectra. This data was processed using the Global Natural 
Products Social Molecular Networking web server 
(www.gnps.ucsd.edu). Novel keramamide analogues were 
assigned based on spectral similarity to known keramamide 
analogues. 
 
Vector preparation 
A PCR product containing krmI and appropriate restriction 
sites was ligated into a vector derived from pET21a using 
standard techniques. The sequence of vectors was confirmed 
by restriction digest and sequencing. 
 
Protein production 
E. coli BL21-DE3, expressing chaperone genes from the 
plasmid pG-KJE8 (TaKaRa Bio) was transformed with the 
vector encoding KrmI. An overnight culture of this was used 
to inoculate LB medium containing appropriate antibiotics 
and chaperone inducers. This was grown at 37 °C to an OD 
of 0.6, then cooled to 16 °C and induced by addition of 
IPTG. The cells were harvested by centrifugation and lysed 
by sonication. The crude lysate was clarified by 
centrifugation. The protein was purified using Ni-NTA 
affinity chromatography, eluting with imidazole. Proteins 
were analyzed by denaturing polyacrylamide gel 
electrophoresis according to standard methods. 
Halogenation assays 
Assays containing purified KrmI or CCL containing KrmI 
along with PrnF, FAD, substrate, NaCl, and NADH, 
(optionally also superoxide dismutase and catalase) in a final 
volume of 0.1 mL, were incubated at 28 °C for 90 minutes 
then quenched by addition of acidic methanol. Samples were 
analyzed by UPLC or LCMS. For preparation of purified 
substrates, the assays were scaled up to 10 mL and purified 
by semi-preparative HPLC. 
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